Filter posts

Jim Greenwood on the Road: Opening Bell at NASDAQ

Jim Greenwood, BIO’s President and CEO, rang the opening bell this morning at the NASDAQ …

Wall Street Journal Highlights Promising Gene Therapy Advances

Yesterday, bluebird bio reported some very uplifting news at the annual meeting of the American …

Jim Greenwood Op-Ed: Time to Fund Medical Countermeasures against Threats like Ebola

On Friday, The Hill published an op-ed from BIO President and CEO Jim Greenwood calling …

BIO Member Company Achieves Significant Milestone in Advanced Biofuel Technology

On Friday, October 17, 2014, Abengoa Bioenergy opened its 25-million gallon per year cellulosic ethanol …

Ebola Highlights Importance of Vaccine Development in Protecting Global Health

The current Ebola crisis shows how government regulators and research institutions, global health organizations, and …

Cancer drugs save and extend lives

This week, CBS aired a misleading segment on the cost of innovative cancer therapies. BIO …

San Francisco Chronicle: High Drug Co-Pays Deny Needed Treatments

Today, the San Francisco Chronicle published an op-ed that I wrote on the importance of …

Jim Greenwood in WSJ: Curing Hepatitis C Is Cheaper Than Open-Ended Care

On Friday, a letter from BIO President and CEO Jim Greenwood was published in the …

Delivering on Biotech’s Promise to Treat Anthrax, Smallpox, Ebola

Thanks to federal biodefense programs that partner with industry to develop and stockpile medical countermeasures, …

Welcome to San Diego!

Welcome to the 2014 BIO International Convention. It has been an exciting and important year …